{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:54:05Z","timestamp":1792144445596,"version":"4.4.0"},"reference-count":231,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014761","name":"Hope Center for Neurological Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neuint.2021.105074","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:54:34Z","timestamp":1621846474000},"page":"105074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Epigenetic regulation in Huntington's disease"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7195-554X","authenticated-orcid":false,"given":"Jae Wook","family":"Hyeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1751-8493","authenticated-orcid":false,"given":"Albert H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6548-0920","authenticated-orcid":false,"given":"Hiroko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2021.105074_bib1","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1093\/hmg\/ddv099","article-title":"Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice","volume":"24","author":"Achour","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","article-title":"Single-nucleus RNA-seq identifies Huntington disease astrocyte states","volume":"8","author":"Al-Dalahmah","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neuint.2021.105074_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/hmg\/ddx006","article-title":"High resolution time-course mapping of early transcriptomic, molecular and cellular phenotypes in Huntington's disease CAG knock-in mice across multiple genetic backgrounds","volume":"26","author":"Ament","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/hmg\/ddu561","article-title":"Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains","volume":"24","author":"Bai","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.aax3338","article-title":"Huntington's disease alters human neurodevelopment","volume":"369","author":"Barnat","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005747","article-title":"Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington's disease","volume":"4","author":"Benn","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","article-title":"Epigenetic regulation in neurodegenerative diseases","volume":"41","author":"Berson","year":"2018","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib8","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/hmg\/ddv006","article-title":"Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation","volume":"24","author":"Biagioli","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuint.2021.105074_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Bobrowska","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2016.05.013","article-title":"The aging epigenome","volume":"62","author":"Booth","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuint.2021.105074_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nbd.2010.02.003","article-title":"The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease","volume":"39","author":"Buckley","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib13","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1093\/brain\/awx272","article-title":"Epigenetic editing of the Dlg4\/PSD95 gene improves cognition in aged and Alzheimer's disease mice","volume":"140","author":"Bustos","year":"2017","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib14","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1073\/pnas.100340697","article-title":"CpG methylation as a mechanism for the regulation of E2F activity","volume":"97","author":"Campanero","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41583-019-0121-9","article-title":"How the epigenome integrates information and reshapes the synapse","volume":"20","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev.genet.032608.103928","article-title":"Histones: annotating chromatin","volume":"43","author":"Campos","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biom7010003","article-title":"DNA methylation targeting: the DNMT\/HMT crosstalk challenge","volume":"7","author":"Castillo-Aguilera","year":"2017","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuint.2021.105074_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2021.105074_bib19","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1523\/JNEUROSCI.5772-12.2013","article-title":"A novel activator of CBP\/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice","volume":"33","author":"Chatterjee","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib20","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708587","article-title":"Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator","volume":"10","author":"Chatterjee","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuint.2021.105074_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mcn.2012.11.011","article-title":"Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases","volume":"55","author":"Chaturvedi","year":"2013","journal-title":"Molecular and cellular neurosciences"},{"key":"10.1016\/j.neuint.2021.105074_bib22","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1523\/JNEUROSCI.1639-11.2011","article-title":"Epigenetic regulation of motor neuron cell death through DNA methylation","volume":"31","author":"Chestnut","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib23","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2021.105074_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3233\/JHD-160226","article-title":"LBH589, A hydroxamic acid-derived HDAC inhibitor, is neuroprotective in mouse models of Huntington's disease","volume":"5","author":"Chopra","year":"2016","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.tig.2020.07.009","article-title":"Emerging insights into the distinctive neuronal methylome","volume":"36","author":"Clemens","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc.2016.83","article-title":"Maintaining cell identity: PRC2-mediated regulation of transcription and cancer","volume":"16","author":"Comet","year":"2016","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.neuint.2021.105074_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrneurol.2012.156","article-title":"Gene expression profiling in human neurodegenerative disease","volume":"8","author":"Cooper-Knock","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib28","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)68144-5","article-title":"Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine","volume":"257","author":"Creusot","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105074_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev-pharmtox-010814-124527","article-title":"DNA methylation and its implications and accessibility for neuropsychiatric therapeutics","volume":"55","author":"Day","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuint.2021.105074_bib31","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/hmg\/ddw076","article-title":"DNA methylation profiling in human Huntington\u2019s disease brain","volume":"25","author":"De Souza","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib231","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nn.3731","article-title":"Maintenance of postmitotic neuronal cell identity","volume":"17","author":"Deneris","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib32","doi-asserted-by":"crossref","first-page":"26114","DOI":"10.1074\/jbc.M109.089433","article-title":"The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation","volume":"285","author":"Dhayalan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105074_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mrrev.2017.09.005","article-title":"The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases","volume":"780","author":"Ding","year":"2019","journal-title":"Mutat. Res."},{"key":"10.1016\/j.neuint.2021.105074_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tig.2009.04.007","article-title":"Instability and chromatin structure of expanded trinucleotide repeats","volume":"25","author":"Dion","year":"2009","journal-title":"Trends Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib35","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/hmg\/ddn019","article-title":"Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline","volume":"17","author":"Dion","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144398","article-title":"The role of H3K4me3 in transcriptional regulation is altered in Huntington's disease","volume":"10","author":"Dong","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib37","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1242\/dev.125.8.1529","article-title":"Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues","volume":"125","author":"Dragatsis","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.neuint.2021.105074_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2008.09.014","article-title":"Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes","volume":"33","author":"Dragileva","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm4043","article-title":"DNA methylation pathways and their crosstalk with histone methylation","volume":"16","author":"Du","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib40","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1016\/j.jmb.2019.09.006","article-title":"H3K36me2\/3 binding and DNA binding of the DNA methyltransferase DNMT3A PWWP domain both contribute to its chromatin interaction","volume":"431","author":"Dukatz","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib41","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00018-017-2717-4","article-title":"CREBBP and p300 lysine acetyl transferases in the DNA damage response","volume":"75","author":"Dutto","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuint.2021.105074_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib43","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1523\/JNEUROSCI.20-09-03175.2000","article-title":"DNA methyltransferase contributes to delayed ischemic brain injury","volume":"20","author":"Endres","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib44","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1097\/00001756-200112040-00032","article-title":"Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons","volume":"12","author":"Endres","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2021.105074_bib45","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.21-03-00788.2001","article-title":"DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals","volume":"21","author":"Fan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib46","doi-asserted-by":"crossref","first-page":"e1558","DOI":"10.1038\/cddis.2014.512","article-title":"DNA methylation and differential gene regulation in photoreceptor cell death","volume":"5","author":"Farinelli","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1242\/dev.121.2.273","article-title":"The eed mutation disrupts anterior mesoderm production in mice","volume":"121","author":"Faust","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.neuint.2021.105074_bib48","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/jnr.20404","article-title":"Dynamic expression of de novo DNA methyltransferases Dnmt3a and Dnmt3b in the central nervous system","volume":"79","author":"Feng","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2021.105074_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.2514","article-title":"Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons","volume":"13","author":"Feng","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib50","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib51","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1523\/JNEUROSCI.2599-04.2004","article-title":"Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease","volume":"24","author":"Ferrante","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz115","article-title":"MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1","author":"Flower","year":"2019","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib53","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/emboj\/20.10.2536","article-title":"Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription","volume":"20","author":"Fuks","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2021.105074_bib54","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1074\/jbc.M210256200","article-title":"The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation","volume":"278","author":"Fuks","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105074_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105074_bib56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.tibs.2017.10.004","article-title":"Histone marks in the 'driver's seat': functional roles in steering the transcription cycle","volume":"42","author":"Gates","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuint.2021.105074_bib57","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4161\/rna.26706","article-title":"Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis","volume":"10","author":"Gipson","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib58","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-140134","article-title":"Epigenetic mechanisms involved in Huntington's disease pathogenesis","volume":"4","author":"Glajch","year":"2015","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib60","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","article-title":"Identification of genetic factors that modify clinical onset of Huntington's disease","volume":"162","author":"Genetic Modifiers of Huntington's Disease Consortium","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib61","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","article-title":"CAG repeat not polyglutamine length determines timing of Huntington's disease onset","volume":"178","author":"Genetic Modifiers of Huntington's Disease Consortium","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib62","first-page":"2989","article-title":"DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer","volume":"33","author":"Gnyszka","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neuint.2021.105074_bib63","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/hmg\/ddy375","article-title":"FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat","volume":"28","author":"Goold","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib64","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/hmg\/ddh317","article-title":"Genome-wide demethylation destabilizes CTG.CAG trinucleotide repeats in mammalian cells","volume":"13","author":"Gorbunova","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn3427","article-title":"Histone acetylation: molecular mnemonics on the chromatin","volume":"14","author":"Graff","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib66","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-981-13-9913-8_14","article-title":"Astrocytes in Huntington's disease","volume":"1175","author":"Gray","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2011.03.022","article-title":"Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain","volume":"145","author":"Guo","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nn.3607","article-title":"Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain","volume":"17","author":"Guo","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11515-014-1295-1","article-title":"Genome-wide antagonism between 5-hydroxymethylcytosine and DNA methylation in the adult mouse brain","volume":"9","author":"Guo","year":"2014","journal-title":"Front. Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/gm80","article-title":"Huntington's disease: the case for genetic modifiers","volume":"1","author":"Gusella","year":"2009","journal-title":"Genome Med."},{"key":"10.1016\/j.neuint.2021.105074_bib71","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington's disease. Movement disorders","volume":"29","author":"Gusella","year":"2014","journal-title":"official journal of the Movement Disorder Society"},{"key":"10.1016\/j.neuint.2021.105074_bib72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnmol.2019.00335","article-title":"Evaluation of biochemical and epigenetic measures of peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in Huntington's disease patients","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib84","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nn.4532","article-title":"Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice","volume":"20","author":"HD iPSC Consortium","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib73","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","article-title":"Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib74","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1038\/s41598-018-28185-4","article-title":"Early alteration of epigenetic-related transcription in Huntington's disease mouse models","volume":"8","author":"Hervas-Corpion","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2021.105074_bib75","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/1073858415579635","article-title":"DNA methylation in memory formation: emerging insights","volume":"21","author":"Heyward","year":"2015","journal-title":"Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry"},{"key":"10.1016\/j.neuint.2021.105074_bib76","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib77","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib78","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/mds.21632","article-title":"Sodium phenylbutyrate in Huntington's disease: a dose-finding study","volume":"22","author":"Hogarth","year":"2007","journal-title":"Mov. Disord. : official journal of the Movement Disorder Society"},{"key":"10.1016\/j.neuint.2021.105074_bib79","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","article-title":"DNA methylation age of human tissues and cell types","volume":"14","author":"Horvath","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib80","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.18632\/aging.101005","article-title":"Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels","volume":"8","author":"Horvath","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neuint.2021.105074_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/epi.4.1.7733","article-title":"Chromatin dynamics coupled to DNA repair","volume":"4","author":"Huertas","year":"2009","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuint.2021.105074_bib82","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/emm.2017.11","article-title":"Writing, erasing and reading histone lysine methylations","volume":"49","author":"Hyun","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuint.2021.105074_bib83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/oxfordjournals.jbchem.a022755","article-title":"Maintenance-type DNA methyltransferase is highly expressed in post-mitotic neurons and localized in the cytoplasmic compartment","volume":"128","author":"Inano","year":"2000","journal-title":"Journal of biochemistry"},{"key":"10.1016\/j.neuint.2021.105074_bib85","first-page":"4117","article-title":"Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations","volume":"27","author":"Irmak","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib86","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/genes8060148","article-title":"CpG and non-CpG methylation in epigenetic gene regulation and brain function","volume":"8","author":"Jang","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.neuint.2021.105074_bib88","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1093\/nar\/gkw723","article-title":"Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm","volume":"44","author":"Jeltsch","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuint.2021.105074_bib89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pneurobio.2011.04.013","article-title":"DNA repair deficiency in neurodegeneration","volume":"94","author":"Jeppesen","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2021.105074_bib90","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1093\/hmg\/dds379","article-title":"Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems","volume":"21","author":"Jia","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib91","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","article-title":"Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease","volume":"46","author":"Jia","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib92","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1073\/pnas.1415195112","article-title":"HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation","volume":"112","author":"Jia","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152498","article-title":"The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington's disease mice","volume":"11","author":"Jia","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib94","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib95","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington's disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuint.2021.105074_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/561","article-title":"Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription","volume":"19","author":"Jones","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib97","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1126\/science.1139517","article-title":"CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease","volume":"315","author":"Jung","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcell.2014.00049","article-title":"Epigenetics across the human lifespan","volume":"2","author":"Kanherkar","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.neuint.2021.105074_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25112496","article-title":"Resolving DNA damage: epigenetic regulation of DNA repair","volume":"25","author":"Karakaidos","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2021.105074_bib100","first-page":"509","article-title":"Huntington's disease as neurodevelopmental disorder: altered chromatin regulation, coding, and non-coding RNA transcription","volume":"9","author":"Kerschbamer","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib101","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1074\/jbc.REV119.007678","article-title":"On the wrong DNA track: molecular mechanisms of repeat-mediated genome instability","volume":"295","author":"Khristich","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105074_bib102","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5607\/en.2014.23.1.36","article-title":"Therapeutic approaches for inhibition of protein aggregation in Huntington's disease","volume":"23","author":"Kim","year":"2014","journal-title":"Experimental neurobiology"},{"key":"10.1016\/j.neuint.2021.105074_bib103","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib104","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2020.05.012","article-title":"Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects","volume":"107","author":"Kim","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/jhg.2013.66","article-title":"Histone modifications for human epigenome analysis","volume":"58","author":"Kimura","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib106","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708547","article-title":"DNA methylation inhibitor attenuates polyglutamine-induced neurodegeneration by regulating Hes5","volume":"11","author":"Kondo","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuint.2021.105074_bib107","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","article-title":"The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain","volume":"324","author":"Kriaucionis","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib108","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143563","article-title":"RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"10","author":"Labadorf","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's disease: underlying molecular mechanisms and emerging concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuint.2021.105074_bib111","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib112","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","article-title":"The epigenetics of aging and neurodegeneration","volume":"131","author":"Lardenoije","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2021.105074_bib113","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026575","article-title":"Role of the polycomb repressive complex 2 (PRC2) in transcriptional regulation and cancer","volume":"6","author":"Laugesen","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.neuint.2021.105074_bib114","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52981","article-title":"Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndrome","volume":"9","author":"Lavery","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neuint.2021.105074_bib115","doi-asserted-by":"crossref","first-page":"42875","DOI":"10.1038\/srep42875","article-title":"Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature","volume":"7","author":"Le Gras","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2021.105074_bib116","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/77046","article-title":"Gene-expression profile of the ageing brain in mice","volume":"25","author":"Lee","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib117","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00401-013-1103-z","article-title":"Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease","volume":"125","author":"Lee","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2021.105074_bib118","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-017-1732-8","article-title":"Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease","volume":"134","author":"Lee","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2021.105074_bib119","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/hmg\/ddx286","article-title":"A modifier of Huntington's disease onset at the MLH1 locus","volume":"26","author":"Lee","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib120","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","article-title":"Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation","volume":"107","author":"Lee","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2021.105074_bib121","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","article-title":"Targeted mutation of the DNA methyltransferase gene results in embryonic lethality","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib122","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/nn.3564","article-title":"EZH2-mediated H3K27 trimethylation mediates neurodegeneration in ataxia-telangiectasia","volume":"16","author":"Li","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","article-title":"Polyglutamine repeats in neurodegenerative diseases","volume":"14","author":"Lieberman","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.neuint.2021.105074_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024620","article-title":"D-beta-hydroxybutyrate is protective in mouse models of Huntington's disease","volume":"6","author":"Lim","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature08514","article-title":"Human DNA methylomes at base resolution show widespread epigenomic differences","volume":"462","author":"Lister","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib126","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/hmg\/ddaa196","article-title":"Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out","volume":"29","author":"Loupe","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib127","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"429","author":"Lu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fnagi.2013.00085","article-title":"DNA methylation, a hand behind neurodegenerative diseases","volume":"5","author":"Lu","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib129","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1038\/s41467-020-18255-5","article-title":"DNA methylation study of Huntington's disease and motor progression in patients and in animal models","volume":"11","author":"Lu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2021.105074_bib130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/38444","article-title":"Crystal structure of the nucleosome core particle at 2.8 A resolution","volume":"389","author":"Luger","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib131","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib132","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib133","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/jnci\/dji311","article-title":"DNA methyltransferase inhibitors and the development of epigenetic cancer therapies","volume":"97","author":"Lyko","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.neuint.2021.105074_bib134","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcb.2017.02.004","article-title":"Mitochondria and epigenetics - crosstalk in homeostasis and stress","volume":"27","author":"Matilainen","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib136","article-title":"Huntington's disease: a clinical review","author":"McColgan","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041423","article-title":"Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease","volume":"7","author":"McFarland","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib138","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/JHD-130066","article-title":"Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease","volume":"2","author":"McFarland","year":"2013","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib139","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/hmg\/ddt499","article-title":"MeCP2: a novel Huntingtin interactor","volume":"23","author":"McFarland","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib140","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.cell.2012.11.022","article-title":"MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system","volume":"151","author":"Mellen","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib141","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.celrep.2019.02.003","article-title":"Cell-type-specific gene expression profiling in adult mouse brain reveals normal and disease-state signatures","volume":"26","author":"Merienne","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2021.105074_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001717","article-title":"HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration","volume":"11","author":"Mielcarek","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib144","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fcvm.2020.00028","article-title":"Epigenetic control of mitochondrial function in the vasculature","volume":"7","author":"Mohammed","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.neuint.2021.105074_bib145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2021.105074_bib146","doi-asserted-by":"crossref","first-page":"359","DOI":"10.31887\/DCNS.2014.16.3\/mmorris","article-title":"Role of DNA methylation and the DNA methyltransferases in learning and memory","volume":"16","author":"Morris","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib147","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","article-title":"Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study","volume":"16","author":"Moss","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031080","article-title":"Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease","volume":"7","author":"Moumne","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2021.105074_bib149","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41588-019-0575-8","article-title":"A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo","volume":"52","author":"Nakamori","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib151","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib152","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-014-0060-2","article-title":"A common gene expression signature in Huntington's disease patient brain regions","volume":"7","author":"Neueder","year":"2014","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.neuint.2021.105074_bib153","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41598-017-01510-z","article-title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients","volume":"7","author":"Neueder","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2021.105074_bib154","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","article-title":"Extensive changes in DNA methylation are associated with expression of mutant huntingtin","volume":"110","author":"Ng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib155","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib156","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib157","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib158","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","article-title":"N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking","volume":"28","author":"Orr","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib159","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fnmol.2019.00258","article-title":"The role of microglia and astrocytes in Huntington's disease","volume":"12","author":"Palpagama","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib160","doi-asserted-by":"crossref","first-page":"31022","DOI":"10.1038\/srep31022","article-title":"Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity","volume":"6","author":"Pan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2021.105074_bib161","doi-asserted-by":"crossref","first-page":"11850","DOI":"10.1074\/jbc.RA117.001211","article-title":"The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity","volume":"293","author":"Pan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105074_bib162","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib163","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.coph.2010.04.004","article-title":"Regulatory signal transduction pathways for class IIa histone deacetylases","volume":"10","author":"Parra","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuint.2021.105074_bib164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003930","article-title":"Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches","volume":"9","author":"Pinto","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-444-63233-3.00005-1","article-title":"Epigenetic mechanisms underlying nervous system diseases","volume":"147","author":"Qureshi","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib166","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2174\/1567205013666160622112234","article-title":"The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis","volume":"13","author":"Riva","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuint.2021.105074_bib167","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagrm.2014.02.007","article-title":"Understanding the relationship between DNA methylation and histone lysine methylation","volume":"1839","author":"Rose","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2021.105074_bib168","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib169","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/77023","article-title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci","volume":"25","author":"Rountree","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib170","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1073\/pnas.0737363100","article-title":"Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway","volume":"100","author":"Ryu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib171","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib172","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ncpneuro0199","article-title":"Mechanisms of disease: histone modifications in Huntington's disease","volume":"2","author":"Sadri-Vakili","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib173","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib174","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nan.12608","article-title":"Invited review: epigenetics in neurodevelopment","volume":"46","author":"Salinas","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuint.2021.105074_bib175","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41594-020-0446-0","article-title":"Enhancer RNAs are an important regulatory layer of the epigenome","volume":"27","author":"Sartorelli","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib176","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib177","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ng1950","article-title":"Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer","volume":"39","author":"Schlesinger","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib178","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.dnarep.2015.11.008","article-title":"Disease-associated repeat instability and mismatch repair","volume":"38","author":"Schmidt","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.neuint.2021.105074_bib179","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/hmg\/ddp524","article-title":"Huntingtin facilitates polycomb repressive complex 2","volume":"19","author":"Seong","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","article-title":"What have we learned from gene expression profiles in Huntington's disease?","volume":"45","author":"Seredenina","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105074_bib181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","article-title":"Transcriptional dysregulation in Huntington's disease: the role of histone deacetylases","volume":"100","author":"Sharma","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuint.2021.105074_bib182","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0512","article-title":"DNA modifications in the mammalian brain","volume":"369","author":"Shin","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuint.2021.105074_bib183","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fphar.2020.00537","article-title":"Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation","volume":"11","author":"Shukla","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2021.105074_bib184","doi-asserted-by":"crossref","first-page":"E8765","DOI":"10.1073\/pnas.1807962115","article-title":"Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition","volume":"115","author":"Siebzehnrubl","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrg3354","article-title":"DNA methylation: roles in mammalian development","volume":"14","author":"Smith","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib186","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nbt.1732","article-title":"Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine","volume":"29","author":"Song","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuint.2021.105074_bib187","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2021.105074_bib188","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/hmg\/ddx432","article-title":"Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease","volume":"27","author":"Song","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib189","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddm064","article-title":"Modulation of nucleosome dynamics in Huntington's disease","volume":"16","author":"Stack","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib190","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib191","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib192","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.neuint.2021.105074_bib193","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cell.2018.08.005","article-title":"Disease-associated short tandem repeats Co-localize with chromatin domain boundaries","volume":"175","author":"Sun","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib194","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib195","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/nn.2959","article-title":"5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging","volume":"14","author":"Szulwach","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib196","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0959-437X(93)90027-M","article-title":"Effects of DNA methylation on DNA-binding proteins and gene expression","volume":"3","author":"Tate","year":"1993","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuint.2021.105074_bib197","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2021.105074_bib198","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib199","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1097-2765(02)00453-7","article-title":"Association of CBP\/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription","volume":"9","author":"Tini","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuint.2021.105074_bib200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fncel.2015.00331","article-title":"Dynamic DNA methylation in the brain: a new epigenetic mark for experience-dependent plasticity","volume":"9","author":"Tognini","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003280","article-title":"MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice","volume":"9","author":"Tome","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib203","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1523\/JNEUROSCI.0670-13.2013","article-title":"Genomic landscape of transcriptional and epigenetic dysregulation in early onset polyglutamine disease","volume":"33","author":"Valor","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib204","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1101\/gad.289140.116","article-title":"Undercover: gene control by metabolites and metabolic enzymes","volume":"30","author":"van der Knaap","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuint.2021.105074_bib205","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tcb.2019.05.004","article-title":"The complexity of PRC2 subcomplexes","volume":"29","author":"van Mierlo","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib206","doi-asserted-by":"crossref","first-page":"E3027","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib207","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","article-title":"Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease","volume":"15","author":"Villar-Menendez","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.neuint.2021.105074_bib208","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature04431","article-title":"The Polycomb group protein EZH2 directly controls DNA methylation","volume":"439","author":"Vire","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib209","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nn.4360","article-title":"Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration","volume":"19","author":"von Schimmelmann","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib210","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2021.105074_bib211","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddt214","article-title":"Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cns.12059","article-title":"A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons","volume":"19","author":"Wang","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuint.2021.105074_bib213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1534-3","article-title":"The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscape","volume":"573","author":"Weinberg","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2021.105074_bib214","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuint.2021.105074_bib216","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-213X-5-17","article-title":"Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo","volume":"5","author":"Woda","year":"2005","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.neuint.2021.105074_bib217","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12929-020-00636-z","article-title":"Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases","volume":"27","author":"Wu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuint.2021.105074_bib218","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg.2017.33","article-title":"TET-mediated active DNA demethylation: mechanism, function and beyond","volume":"18","author":"Wu","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib219","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1038\/srep07645","article-title":"Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress","volume":"5","author":"Xin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2021.105074_bib220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib221","doi-asserted-by":"crossref","first-page":"24840","DOI":"10.1073\/pnas.1908113116","article-title":"Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease","volume":"116","author":"Yildirim","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105074_bib222","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105074_bib223","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fneur.2018.00655","article-title":"DNA methylation profiles in whole blood of Huntington's disease patients","volume":"9","author":"Zadel","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuint.2021.105074_bib224","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","article-title":"Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease","volume":"94","author":"Zadori","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuint.2021.105074_bib225","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib226","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1101\/gad.13.15.1924","article-title":"Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation","volume":"13","author":"Zhang","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuint.2021.105074_bib227","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1093\/nar\/gkq147","article-title":"Chromatin methylation activity of Dnmt3a and Dnmt3a\/3L is guided by interaction of the ADD domain with the histone H3 tail","volume":"38","author":"Zhang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuint.2021.105074_bib228","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuint.2021.105074_bib229","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105074_bib230","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J. Neurosci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018621001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018621001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:55:34Z","timestamp":1759312534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018621001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":231,"alternative-id":["S0197018621001200"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2021.105074","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic regulation in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2021.105074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105074"}}